Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about LNAI, unsubscribe in one click. Privacy
LNAI holds $491,645 in cash and short-term investments and burns about $133,163/quarter from operations, an estimated runway of 11.1 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 60 · High
These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are issued.10-Q, May 2026
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LNAI files for a raise →
| Holder | Type | Shares | % of shares | As of |
|---|---|---|---|---|
| Vanguard Group Inc | Institution (13F) | 497,011 | 1.37% | 2025-12-31 |
| Millennium Management Llc | Institution (13F) | 166,744 | 0.46% | 2025-12-31 |
| Geode Capital Management, LLC | Institution (13F) | 131,015 | 0.36% | 2025-12-31 |
| Blackrock Inc. | Institution (13F) | 127,314 | 0.35% | 2025-12-31 |
| Northern Trust Corporation | Institution (13F) | 37,402 | 0.10% | 2025-12-31 |
| State Street Corporation | Institution (13F) | 35,728 | 0.10% | 2025-12-31 |
| Nine Masts Capital Ltd. | Institution (13F) | 24,220 | 0.07% | 2025-12-31 |
| Citadel Advisors Llc | Institution (13F) | 20,632 | 0.06% | 2025-12-31 |
| UBS Group AG | Institution (13F) | 17,940 | 0.05% | 2025-12-31 |
| Jane Street Group, LLC | Institution (13F) | 11,900 | 0.03% | 2025-12-31 |
Share count 36,271,119 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest (13F quarter ending 2025-12-31). Sources have different dates, so the split is approximate. Source: SEC EDGAR.
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LNAI and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →